Droplet Biosciences Cuts Genomic Analysis Time Using NVIDIA GPU Technology
Droplet Biosciences reports reducing genomic analysis time from days to hours for its LymphDetect test by adopting NVIDIA Parabricks GPU-accelerated software.
Read More
Search Results for: liver disease
Study Shows Dual Epigenetic Markers Improve Early Colorectal Cancer Detection
A study reports that dual epigenetic markers in cell-free DNA achieved 95% diagnostic accuracy for stage I colorectal cancer, outperforming conventional liquid biopsy methods.
Read More
Lucent Diagnostics Partners to Bring Blood-Based Alzheimer’s Testing to Community Settings
The collaboration will expand access to Alzheimer’s biomarker testing through mobile delivery to community centers, churches, and senior centers nationwide.
Read More
Mursla Bio Joins ABHI US Accelerator Program to Launch Liver Cancer Test
Mursla Bio has joined the ABHI US Accelerator program to support the US launch of EvoLiver, an FDA-designated liver cancer surveillance test, gaining access to 300-plus healthcare leaders across 35 hospitals and 20 health systems.
Read More
AI Liquid Biopsy Test Detects Early Liver Fibrosis and Cirrhosis
Johns Hopkins researchers have developed an AI-driven liquid biopsy that uses cell-free DNA fragmentation patterns to detect early liver fibrosis and cirrhosis, according to a study in Science Translational Medicine.
Read More